Pfizer Phase 1 - 2 Trial Data on RSV Vaccine Candidate

preview_player
Показать описание
Dr. Phil Dormitzer, VP and CSO, Viral Vaccines at Pfizer Vaccines Research and Development discusses the significance of new data presented at the 2019 IDWeek conference for a respiratory syncytial virus (RSV) vaccine candidate. The vaccine is currently in Phase 2b trials in pregnant women in the United States and the Phase 1/2 data being presented at IDWeek show encouraging safety and immune response. No vaccine is currently licensed for use specifically in pregnant women to protect infants.

#RSV #RSVVacine #Pfizer

Visit our website

Follow us on our social media channels

Subscribe to our podcast channels

Support us on Patreon
  1. HPR
  2. Health
  3. Health News
  4. Health Topics
  5. Health radio
  6. Health Professional Radio
Рекомендации по теме
Pfizer Phase 1 0:09:25

Pfizer Phase 1 - 2 Trial Data on RSV Vaccine Candidate

Development of new 0:02:46

Development of new medicine : the steps of Phase 1

Pfizer A 0:12:16

Pfizer A Phase 1 2 3 Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy

Pfizer A Phase 0:12:16

Pfizer A Phase 1 2 3 Study to Evaluate the Safety Tolerability Immunogenicity and Efficacy

PFIZER INC STOCK 0:06:20

PFIZER INC STOCK PHASE 1/2 TRIAL RESULTS!!! BUY NOW?!!!(PFE)🚨BIOTECH STOCKS LIVE ANALYSIS!🎯

Respiratory syncytial virus 0:09:16

Respiratory syncytial virus treatment - rsv (respiratory syncytial virus): what you should know

New Pfizer Document 0:00:44

New Pfizer Document April 2022 Release | Revealed it was never meant to be a 2-dose vaccine #shorts

J&J reports positive 0:07:08

J&J reports positive phase 1/2 Covid-19 vaccine trial results

Novel Treatment Approaches 1:57:43

Novel Treatment Approaches for Urothelial Bladder Cancer and Prostate Cancer

Coronavirus: Pfizer, BioNTech 0:01:41

Coronavirus: Pfizer, BioNTech see early positive results for vaccine candidate

Pfizer COVID 19 0:02:56

Pfizer COVID 19 vaccination guide UK

COVID Focus Talk 0:08:58

COVID Focus Talk || Pfizer's future oral med for COVID || Why this drug could be a game changer...

Pfizer In Final 0:02:14

Pfizer In Final Phase Of Development On Coronavirus Vaccine

mRNA future 0:17:11

mRNA future

Pfizer COVID-19 Vaccine 0:03:27

Pfizer COVID-19 Vaccine Produced 4.6 Times More Antibodies in Participants

Novavax begins phase 0:00:48

Novavax begins phase 1 clinical trial of COVID-19 vaccine candidate

Pfizer weight-loss pills 0:00:32

Pfizer weight-loss pills may work as well as shots

Pfizer research chief 0:04:56

Pfizer research chief on early positive vaccine results

Phases of a 0:06:10

Phases of a Clinical Trial

BREAKING | Pfizer 0:00:46

BREAKING | Pfizer reports encouraging phase 3 data from potential COVID-19 vaccine

Pfizer new antiviral 0:26:03

Pfizer new antiviral

Phase 3 data 0:02:17

Phase 3 data shows Pfizer, Moderna have at least 6-month immunity, can researchers look back at Phas

Covid-19: BioNTech, Pfizer 0:00:49

Covid-19: BioNTech, Pfizer report progress in coronavirus vaccine trial

Moderna Coronavirus Vaccine 0:00:40

Moderna Coronavirus Vaccine Shows Promising Results In Phase 1